Bayer has bolstered its cell and gene therapy platform by securing access to a CRISPR-based gene-editing platform developed by US biotech Mammoth Biosciences. The German group is paying $40 ...
Neste and Bayer have signed a memorandum of understanding aimed at developing a winter canola ecosystem in the US. This includes identifying partners and developing the value chain together and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback